Jun. 8 at 4:27 AM
$RCEL
From my interaction with ChatGPT (some edits due to formatting):
"after looking into Joe Woody's background, I think the Avanos connection is actually more relevant than I initially realized.
The key point is that he wasn't just an executive at Avanos.
He was the CEO of Avanos Medical from 2017–2024 and served on its board. Before that, he was CEO of Acelity, one of the largest wound-care and regenerative medicine companies in the world. Prior to that, he led the Advanced Wound Management division at Smith & Nephew.
That resume is remarkably aligned with what AVITA is trying to accomplish.
The Acelity Connection May Be The Most Important
Before Avanos, Woody was CEO of Acelity, where he oversaw a roughly
$2 billion wound-care and regenerative solutions business. He also previously led Smith & Nephew's Advanced Wound Management business."
Always do your own due diligence. My posts may have errors. This is for entertainment purposes only. Nothing I post is financial advice.
